A New Era of Prostate Cancer Precision Medicine.
biomarkers
gene fusion
genome editing
liquid biopsy
non-coding genome
precision medicine
prostate cancer
proteomic technologies
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
06
2019
accepted:
31
10
2019
entrez:
19
12
2019
pubmed:
19
12
2019
medline:
19
12
2019
Statut:
epublish
Résumé
Prostate cancer is the second most common male cancer affecting Western society. Despite substantial advances in the exploration of prostate cancer biomarkers and treatment strategies, men are over diagnosed with inert prostate cancer, while there is also a substantial mortality from the invasive disease. Precision medicine is the management of treatment profiles across different cancers predicting therapies for individual cancer patients. With strategies including individual genomic profiling and targeting specific cancer pathways, precision medicine for prostate cancer has the potential to impose changes in clinical practices. Some of the recent advances in prostate cancer precision medicine comprise targeting gene fusions, genome editing tools, non-coding RNA biomarkers, and the promise of liquid tumor profiling. In this review, we will discuss these recent scientific advances to scale up these approaches and endeavors to overcome clinical barriers for prostate cancer precision medicine.
Identifiants
pubmed: 31850193
doi: 10.3389/fonc.2019.01263
pmc: PMC6901987
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1263Informations de copyright
Copyright © 2019 Malik, Srinivasan and Batra.
Références
Drug Discov Today Technol. 2018 Aug;28:3-12
pubmed: 30205878
Curr Opin Urol. 2016 May;26(3):231-9
pubmed: 26909474
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
Nat Genet. 2001 Mar;27(3):234-6
pubmed: 11242096
Oncogene. 2015 Jul;34(29):3815-25
pubmed: 25263440
Sci Transl Med. 2012 Mar 28;4(127):127rv3
pubmed: 22461644
Target Oncol. 2016 Oct;11(5):569-577
pubmed: 27402433
J Urol. 2013 Mar;189(3):1110-6
pubmed: 22999998
Exp Ther Med. 2018 Sep;16(3):2527-2533
pubmed: 30186486
JAMA. 2018 Mar 6;319(9):883-895
pubmed: 29509864
Asian J Androl. 2014 Jul-Aug;16(4):549-54
pubmed: 24830695
Nat Rev Genet. 2016 Jul;17(7):392-406
pubmed: 27140283
Nat Med. 2011 Feb;17(2):211-5
pubmed: 21240262
Sci Rep. 2017 Jul 31;7(1):6880
pubmed: 28761119
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
Tumour Biol. 2014 Sep;35(9):8573-80
pubmed: 24863945
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
J Clin Oncol. 2018 Apr 1;36(10):991-999
pubmed: 29261439
Nat Rev Urol. 2011 Mar;8(3):123-4
pubmed: 21394175
BMJ. 2018 Jan 10;360:j5757
pubmed: 29321194
Cancer. 2019 May 1;125(9):1459-1469
pubmed: 30620391
Clin Chem. 2013 Nov;59(11):1595-603
pubmed: 23958847
Nat Genet. 2018 Jun;50(6):814-824
pubmed: 29808028
Nat Genet. 2009 May;41(5):619-24
pubmed: 19396168
Curr Treat Options Oncol. 2017 Jun;18(6):37
pubmed: 28540598
J Exp Clin Cancer Res. 2015 Feb 06;34:15
pubmed: 25651917
Nat Rev Drug Discov. 2018 Aug 30;17(9):613
pubmed: 30160250
Mol Cancer. 2017 Apr 14;16(1):80
pubmed: 28410618
Int Urol Nephrol. 2018 Sep;50(9):1619-1626
pubmed: 30014459
Lancet Oncol. 2015 Dec;16(16):1667-76
pubmed: 26563502
Genet Med. 2015 Oct;17(10):789-95
pubmed: 25569441
PLoS One. 2015 May 01;10(5):e0125277
pubmed: 25933120
J Exp Clin Cancer Res. 2017 Dec 28;36(1):192
pubmed: 29282151
ACS Nano. 2017 Mar 28;11(3):2618-2627
pubmed: 28240870
Cancer Cell. 2017 Apr 10;31(4):532-548.e7
pubmed: 28344039
Clin Cancer Res. 2017 Oct 1;23(19):5981-5992
pubmed: 28645941
J Urol. 2016 Nov;196(5):1436-1444
pubmed: 27238617
Molecules. 2018 Apr 04;23(4):
pubmed: 29617327
Antimicrob Agents Chemother. 1982 Jul;22(1):55-61
pubmed: 6289741
Oncotarget. 2015 Sep 29;6(29):27049-64
pubmed: 26267323
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Nature. 1979 Jul 26;280(5720):339-40
pubmed: 460409
Prostate. 2014 Jan;74(1):103-11
pubmed: 24115268
Prostate Cancer Prostatic Dis. 2019 Mar;22(1):137-142
pubmed: 30171228
Mol Cell Proteomics. 2009 May;8(5):1006-15
pubmed: 19068476
J Cancer Res Ther. 2014 Nov;10 Suppl:C218-21
pubmed: 25450286
Sci Rep. 2019 Jul 24;9(1):10739
pubmed: 31341219
Anal Bioanal Chem. 2009 Jun;394(4):1117-24
pubmed: 19132354
Int J Biol Macromol. 2019 Feb 1;122:1235-1243
pubmed: 30219508
Cell. 1980 Feb;19(2):313-9
pubmed: 6986989
N Engl J Med. 2008 Feb 28;358(9):910-9
pubmed: 18199855
Nat Genet. 2013 Apr;45(4):385-91, 391e1-2
pubmed: 23535732
J Urol. 2014 Oct;192(4):1081-7
pubmed: 24747657
Urol Oncol. 2014 Jan;32(1):53.e15-22
pubmed: 24239470
Oncol Rep. 2015 Dec;34(6):3247-55
pubmed: 26503549
J Control Release. 2016 May 10;229:1-9
pubmed: 26956592
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Cell. 2019 Feb 7;176(4):831-843.e22
pubmed: 30735634
Urol Oncol. 2014 Apr;32(3):252-60
pubmed: 24495450
JAMA Oncol. 2017 Aug 01;3(8):1085-1093
pubmed: 28520829
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
Curr Oncol. 2010 Sep;17 Suppl 2:S72-9
pubmed: 20882137
Proteomics Clin Appl. 2018 Mar;12(2):
pubmed: 29521035
Clin Cancer Res. 2014 Sep 1;20(17):4442-8
pubmed: 24958807
Clin Chem. 2016 Oct;62(10):1318-33
pubmed: 27540032
Asian J Androl. 2016 Jul-Aug;18(4):559-67
pubmed: 27056344
Cell. 2019 Jan 10;176(1-2):98-112.e14
pubmed: 30633912
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
Ann Oncol. 2017 Nov 1;28(11):2658-2669
pubmed: 29045523
CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40
pubmed: 4625049
N Engl J Med. 2014 Jul 31;371(5):424-33
pubmed: 24881730
Nat Rev Cancer. 2008 Jul;8(7):497-511
pubmed: 18563191
Nat Commun. 2018 Feb 28;9(1):883
pubmed: 29491376
Mol Ther. 2011 Oct;19(10):1878-86
pubmed: 21829171
Cancer Lett. 2017 Sep 28;404:53-61
pubmed: 28716526
Oncotarget. 2017 Jul 25;8(30):49133-49143
pubmed: 28467780
Nat Biotechnol. 2017 Jun;35(6):543-550
pubmed: 28459452
J Clin Oncol. 2011 Jun 1;29(16):2185-90
pubmed: 21464416
Oncogene. 2016 Jan 28;35(4):403-14
pubmed: 25915839
Clin Genitourin Cancer. 2016 Apr;14(2):117-21
pubmed: 26774207
Arch Ital Urol Androl. 2016 Oct 05;88(3):195-200
pubmed: 27711093
J Clin Oncol. 2017 Jul 10;35(20):2240-2250
pubmed: 28448241
Crit Rev Oncol Hematol. 2017 Oct;118:15-26
pubmed: 28917266
Cell. 2019 Feb 7;176(4):869-881.e13
pubmed: 30735636
Eur Urol. 2016 Jul;70(1):45-53
pubmed: 25985884
Genes Dev. 2018 Sep 1;32(17-18):1105-1140
pubmed: 30181359
Oncotarget. 2017 Sep 15;8(48):84338-84348
pubmed: 29137428
J Pathol. 2015 Oct;237(2):226-37
pubmed: 26011734
Metabolomics. 2013 Apr;9(2):444-453
pubmed: 23543897
Int J Nanomedicine. 2019 May 02;14:3111-3128
pubmed: 31118626
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Oncotarget. 2017 Feb 7;8(6):9375-9387
pubmed: 28030843
Oncotarget. 2016 Jul 26;7(30):48832-48841
pubmed: 27223063
Eur Urol. 2018 Aug;74(2):204-210
pubmed: 29331214
Sci Rep. 2019 Feb 26;9(1):2749
pubmed: 30808902
N Engl J Med. 2018 Apr 12;378(15):1408-1418
pubmed: 29420164
Transl Lung Cancer Res. 2016 Aug;5(4):420-3
pubmed: 27655109
Nature. 2019 Feb;566(7743):218-223
pubmed: 30718774
Discov Med. 2016 Nov;22(122):281-295
pubmed: 28009970
JAMA. 2017 Jun 27;317(24):2532-2542
pubmed: 28655021
J Cell Mol Med. 2014 Mar;18(3):371-90
pubmed: 24533657
Trends Mol Med. 2018 Mar;24(3):257-277
pubmed: 29449148
Proteome Sci. 2015 Jan 29;13(1):2
pubmed: 25653573
Eur Urol. 2015 Oct;68(4):555-67
pubmed: 25964175
J Mol Diagn. 2017 May;19(3):475-484
pubmed: 28341589
Am J Pathol. 2015 Jul;185(7):1834-45
pubmed: 25963990
Oncotarget. 2017 Jun 27;8(26):42438-42454
pubmed: 28465491
Future Oncol. 2016 Jan;12(1):43-57
pubmed: 26615920
Science. 2015 Sep 18;349(6254):1351-6
pubmed: 26383955
Proteomics. 2017 Feb;17(3-4):
pubmed: 28127880
Eur Urol. 2011 Jul;60(1):21-8
pubmed: 21295399
Cancer. 2009 Dec 1;115(23):5541-9
pubmed: 19711464
PLoS One. 2013 Dec 31;8(12):e82589
pubmed: 24391718
Proteomics. 2015 Mar;15(5-6):1026-38
pubmed: 25429922
Endocr Relat Cancer. 2014 May 06;21(3):R143-52
pubmed: 24659477
Eur Urol. 2016 Nov;70(5):740-748
pubmed: 27108162
Nat Rev Drug Discov. 2018 Feb 28;17(3):156-157
pubmed: 29487392
Clin Cancer Res. 2015 Jun 1;21(11):2591-600
pubmed: 25733599
Eur Urol. 2018 Jan;73(1):4-8
pubmed: 28851578
Cell Physiol Biochem. 2018;50(5):1903-1915
pubmed: 30396163
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Nat Commun. 2019 Jul 25;10(1):3328
pubmed: 31346163
Mol Med Rep. 2014 Dec;10(6):3310-4
pubmed: 25242314
Nat Genet. 2018 Jul;50(7):928-936
pubmed: 29892016
Ann Oncol. 2010 Jan;21(1):109-13
pubmed: 19608618
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Curr Opin Cell Biol. 2009 Jun;21(3):416-25
pubmed: 19447594
Med Sci Monit. 2018 May 25;24:3462-3471
pubmed: 29798970
Cancer Biol Ther. 2018 Aug 3;19(8):669-675
pubmed: 29580149
Eur J Pharm Sci. 2017 Feb 15;98:80-85
pubmed: 27664330
J Transl Med. 2018 Dec 14;16(1):356
pubmed: 30547831
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
BMC Genomics. 2015 Dec 01;16:1021
pubmed: 26626734
Sci Rep. 2017 Feb 17;7:42961
pubmed: 28211531
Br J Cancer. 2014 Sep 9;111(6):1201-12
pubmed: 25032733
Nat Commun. 2018 Mar 21;9(1):1176
pubmed: 29563510
Sci Rep. 2017 May 26;7(1):2433
pubmed: 28550299
Endocr Relat Cancer. 2017 May;24(5):R157-R172
pubmed: 28289080
Annu Rev Pathol. 2014;9:287-314
pubmed: 24079833
Nat Rev Genet. 2018 Sep;19(9):581-590
pubmed: 29789686
Nucleic Acids Res. 2015 Feb 18;43(3):e17
pubmed: 25414344
Eur Urol. 2015 Aug;68(2):186-93
pubmed: 25454609
Oncotarget. 2017 Aug 18;8(42):72755-72772
pubmed: 29069824
Prostate. 2017 Oct;77(14):1401-1407
pubmed: 28853167
Noncoding RNA. 2017 Feb 20;3(1):
pubmed: 29657281
J Pathol. 2010 Jan;220(2):244-54
pubmed: 19921709
Nat Rev Genet. 2013 Jul;14(7):507-15
pubmed: 23774735
Ther Adv Urol. 2014 Apr;6(2):74-7
pubmed: 24688603
Prostate. 2015 Apr 1;75(5):539-49
pubmed: 25597828
J Exp Clin Cancer Res. 2017 Jun 28;36(1):90
pubmed: 28659174
Cancers (Basel). 2018 Oct 29;10(11):
pubmed: 30380648
Mol Cancer. 2011 Apr 13;10:38
pubmed: 21489289
Expert Rev Mol Diagn. 2017 Aug;17(8):791-804
pubmed: 28635333
Chem Biol. 2008 Jul 21;15(7):675-82
pubmed: 18635004
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4761-4766
pubmed: 29666232
Cancers (Basel). 2010 Jul 06;2(3):1432-40
pubmed: 24281166
Nat Rev Urol. 2014 Jan;11(1):18-31
pubmed: 24296704